Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
P.1.1 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.600ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.12 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.525 (Eta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
AY.6 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.5.5 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.7 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.134ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.39.1.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
XBC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.2 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
M.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.5.6 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.440ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.23.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.104 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.198ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
XAFENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
P.1.17.1 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.375ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBHENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.78ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.9.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.64ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.221.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.82ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.38.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.79.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used